Destiny Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Destiny Wealth Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,651	Closed	-$100K	–	287
2026 Q1	$100K	Buy	+1,651	New	+$96.2K	0.01%	336
2023 Q1	–	Sell	-4,228	Closed	-$304K	–	234
2022 Q4	$304K	Buy	4,228 +178	+4%	+$13.4K	0.07%	152
2022 Q3	$288K	Buy	4,050 +1,223	+43%	+$88.7K	0.06%	143
2022 Q2	$218K	Buy	2,827 +1,455	+106%	+$111K	0.05%	172
2022 Q1	$100K	Buy	1,372 +412	+43%	+$27.7K	0.02%	240
2021 Q4	$60K	Buy	960 +67	+8%	+$3.93K	0.01%	296
2021 Q3	$53K	Buy	+893	New	+$58.8K	0.01%	284

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Destiny Wealth Partners's BMY Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 1,651 shares — an estimated $100K sold.

Destiny Wealth Partners first reported a position in BMY in Q3 2021 and held it in 7 quarters. The position peaked at $304K in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Destiny Wealth Partners reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Destiny Wealth Partners sold 1,651 Bristol-Myers Squibb shares in Q2 2026, an estimated $100K.
Destiny Wealth Partners first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 7 quarters.
Destiny Wealth Partners's Bristol-Myers Squibb position peaked at $304K in Q4 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.